Vectus Biosystems Limited (ASX:VBS) is developing a treatment for fibrosis and high blood pressure, which includes the treatment for three of the largest diseases in the fibrotic market, namely heart, kidney and liver diseases. Vectus successfully completed its Initial Public Offering (IPO) on the A...See more
Headquarters:
Australia
Company Type:
MNC / Large Enterprise
Company size:
11-50 Employees
Address:
3-11 PRIMROSE AVENUE; ROSEBERY, NSW 2018, AU
Employees by Department
- The Rest (1)
- Total (1)
Key Decision Makers
Financials
LOW
spending power
Discover More Companies
Lookalike companies
Featured Lists
- SMEs in Singapore
- MNCs / Large Enterprises in Singapore
Frequently Asked Questions (FAQ)
- What is the funding status of VECTUS BIOSYSTEMS?
- Where is VECTUS BIOSYSTEMS's headquarter?
- What VECTUS BIOSYSTEMS's spending power?
- Does VECTUS BIOSYSTEMS have a presence in the domain it operates in?

